The synergistic antitumor activity of mitomycin C (MMC) and cisplatin (DDP) against the gastric cancer cell lines MKN-28 and MKN-45 was assessed in vitro using the MTT assay. The synergism of the two agents was evaluated in terms of the interaction index (1.1.). The sequence of MMC followed by DDP s
โฆ LIBER โฆ
Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer
โ Scribed by Stanley C. Hopkins; Robert Matheny; Mark S. Soloway
- Book ID
- 119044715
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 279 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Synergistic antitumor activity of mitomy
โ
Yoshiro Saikawa; Tetsuro Kubota; Tsong-Hong Kuo; Suguru Kase; Toshiharu Furukawa
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 466 KB
Synergistic antitumor activity of combin
โ
Yoshiro Saikawa; Dr. Tetsuro Kubota; Tsong-Hong Kuo; Toshiharu Furukawa; Suguru
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 363 KB
A new combined cancer chemotherapy regimen of mitomycin C (MMC) and cisplatin (DDP) showed synergistic antitumor activity against human gastric cancer xenografts St-40 and SC-1-NU in BALB/c nu/nu mice. The drugs were administered intraperitoneally at doses of 2 or 4 mg/kg for MMC and 3 or 6 mg/kg fo
S152 COMPARISON OF FULL-DOSE INTRAVESICA
โ
H. Yari; M. Fallahnezhad; Karim B. Haji; Shirvan S. Tavasoli
๐
Article
๐
2010
๐
Elsevier Science
๐
English
โ 613 KB